Apollomics Company Profile, Contacts & Intelligence

Biotechnology ResearchCn26 employeesFounded 2015
4 contacts with email or phone data4 with email data3 with phone data
Employees
26
Company source estimate
Reachable Contacts
4
Visible contacts with email or phone data
Contacts With Email
4
4 of 4 visible contacts

Apollomics Overview

Apollomics is an innovative biotechnology company committed to the discovery and development of oncology combination therapies. With operations in both the U.S. and China, we believe we are well positioned to unlock synergies by leveraging the strengths of partnerships with other biotechnology companies in the East and the West. Since our founding in 2015, under the leadership of our experienced management team with in-depth knowledge and expertise of the evolving cancer treatment landscape, we have built a pipeline of ten (10) drug candidates across 12 programs that focus on oncology, of which five (5) drug candidates are at clinical stage. The drug candidates in our existing pipeline can be categorized into three (3) groups based on their mechanisms of action, each of which contains drug candidates at different stages of development. The first group is “tumor inhibitors”, which consists of four (4) small molecule inhibitors against different uncontrolled growth signaling pathways in cancer cells, one of which is our Core Product, a c-Met inhibitor. The second group is “anti-cancer enhancers”, which could enhance the anti-cancer effects of other treatments. This group comprises two (2) antagonists against a cell adhesion receptor, which are being developed as adjuncts to chemotherapy. The last group is “immuno-oncology drugs”, which take the advantage of the body’s immune system to fight cancer. This group comprises four (4) drug candidates, including mono-specific and bi-specific antibodies that releases the natural brakes of immune response against cancer cells, as well as a novel cancer vaccine. Having three (3) groups of drug candidates with different mechanisms of action would enable us to develop potential synergistic combination therapies that address unmet needs in cancer treatment. To learn more about Apollomics, visit our website at https://www.apollomicsinc.com/

Headquarters
Cn
Industry
Biotechnology Research
Founded
2015
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads

Apollomics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

4 contacts with contact data
4 with email data and 3 with phone data in the visible sample.

Apollomics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Apollomics Workforce Composition

Seniority breakdown across 5 visible profiles.

Individual contributor
3
Executive
1
VP / Head
1

Compare Similar Companies to Apollomics

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Genentech Biotechnology Research 18.23K View company
Arcus Biosciences Biotechnology 680 View company
Crown Bioscience Biotechnology Research 568 View company
FibroGen, Inc. Biotechnology Research 300 View company
ALX Oncology Biotechnology Research 73 View company
Imagene Biopharmaceuticals Biotechnology Research 41 View company
Launch Therapeutics Biotechnology 41 View company
Innoforce Pharmaceuticals Pharmaceutical Manufacturing 29 View company
Illexcor Therapeutics, LLC Biotechnology Research 6 View company
CBT Pharmaceuticals Inc. Pharmaceutical Manufacturing 2 View company